These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 16864069

  • 1. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
    Xue J, Waterman F, Handler J, Gressen E.
    Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
    [Abstract] [Full Text] [Related]

  • 2. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
    Chew MS, Xue J, Houser C, Misic V, Cao J, Cornwell T, Handler J, Yu Y, Gressen E.
    Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
    [Abstract] [Full Text] [Related]

  • 3. Localization of linked 125I seeds in postimplant TRUS images for prostate brachytherapy dosimetry.
    Xue J, Waterman F, Handler J, Gressen E.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):912-9. PubMed ID: 15936577
    [Abstract] [Full Text] [Related]

  • 4. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A, Chen H, Grebler A, Geltzeiler J, Geltzeiler M, Keselman I, Litvin S, Sim S, Hanlon A, Yang J.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1631-8. PubMed ID: 15590195
    [Abstract] [Full Text] [Related]

  • 5. Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.
    Haworth A, Ebert M, St Clair S, Carey BM, Flynn A, Bottomley DM, Duchesne GM, Joseph D, Ash D.
    Brachytherapy; 2005 Dec 01; 4(2):146-53. PubMed ID: 15893269
    [Abstract] [Full Text] [Related]

  • 6. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
    Al-Qaisieh B, Witteveen T, Carey B, Henry A, Bottomley D, Smith J, Franks K, Bownes P.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):626-30. PubMed ID: 19540077
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry.
    Sanders JW, Tang C, Kudchadker RJ, Venkatesan AM, Mok H, Hanania AN, Thames HD, Bruno TL, Starks C, Santiago E, Cunningham M, Frank SJ.
    Brachytherapy; 2023 Oct 01; 22(6):822-832. PubMed ID: 37716820
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy.
    Tanaka O, Hayashi S, Sakurai K, Matsuo M, Nakano M, Maeda S, Hoshi H, Deguchi T.
    Radiother Oncol; 2006 Dec 01; 81(3):303-8. PubMed ID: 17125859
    [Abstract] [Full Text] [Related]

  • 15. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
    Merrick GS, Butler WM, Dorsey AT, Lief JH.
    Tech Urol; 2001 Sep 01; 7(3):233-40. PubMed ID: 11575521
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison between postoperative TRUS-CT fusion with MRI-CT fusion for postimplant quality assurance in prostate LDR permanent seed brachytherapy.
    Tisseverasinghe S, Marbán M, Crook J, Petrik D, Araujo C.
    Brachytherapy; 2021 Sep 01; 20(4):849-856. PubMed ID: 33867295
    [Abstract] [Full Text] [Related]

  • 18. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
    D'Souza WD, Thames HD, Kuban DA.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1540-8. PubMed ID: 15050335
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.